GlaxoSmithKline | GSK - Trade Creditors



GlaxoSmithKline reported 14.82B in Trade Creditors for its fiscal quarter ending in June of 2025.


Trade Creditors Change Date
AbbVie 2.94B 2.66B Dec/2024
Alcon AG USD 895M 53M Jun/2025
Almirall EUR 199.39M 50.03M Jun/2025
Amgen USD 18.03B 15.63B Jun/2025
argenx SE 852.2M 369.5M Jun/2025
AstraZeneca 23.99B 1.44B Jun/2025
Bayer EUR 6.04B 549M Jun/2025
Biogen USD 408.4M 16.9M Jun/2025
Bristol-Myers Squibb USD 5.43B 1.42B Jun/2025
Eli Lilly USD 4.08B 633.7M Jun/2025
Fresenius EUR 1.15B 109M Jun/2025
Fresenius Medical Care EUR 751.74M 17.26M Jun/2025
Galapagos EUR 133.18M 35.76M Jun/2025
Genmab 5M 1.22M Mar/2025
Gilead Sciences USD 582M 155M Jun/2025
GlaxoSmithKline 14.82B 329M Jun/2025
Glaxosmithkline 13.65B 10.19B Jun/2025
GRIFOLS EUR 878.68M 26.38M Jun/2025
Hikma Pharmaceutical USD 358M 183M Dec/2024
Lonza CHF 471M 3M Dec/2024
Merck EUR 1.96B 132M Jun/2025
Merck USD 4.04B 261M Jun/2025
Novartis USD 4.51B 245M Jun/2025
Novo Nordisk 28.21B 8.63B Jun/2025
Orion EUR 89.1M 600K Jun/2025
Pfizer USD 5.17B 74M Jun/2025
Philips EUR 1.75B 78M Jun/2025
Recordati EUR 330.22M 4.23M Jun/2025
Regeneron Pharmaceuticals USD 723.9M 18.4M Jun/2025
Roche Holding 4.35B 828M Dec/2024
Sanofi 7.08B 14.54B Jun/2025
Smith & Nephew USD 1.19B 65M Jun/2025
UCB 750M 1.66B Dec/2024